Safety and Efficacy of Biphasic Insulin Aspart 50 in Subjects With Type 2 Diabetes
NCT01650129
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
83
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetes
Diabetes Mellitus, Type 2
Interventions
DRUG:
biphasic insulin aspart 50
DRUG:
biphasic human insulin 50
Sponsor
Novo Nordisk A/S